Although the mechanism underlining the down-regulation of TRAIL in T1DM should be further investigated, these findings suggest how the metabolic endangerment, rather than autoimmunity, is clearly linked to the decrease in the circulating levels of TRAIL. Here, TNFSF10 is linked to type 1 diabetes mellitus.